Missing Parts of Batch Records Lead to 483 for Drugmaker

Drug GMP Report
A A
Incomplete batch records and poor testing of finished drug products resulted in a Form 483 for New York drugmaker Cerovene.

To View This Article:

Login

Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $135.00